Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Discover whether stocks or bonds are better for achieving financial freedom. Start making smarter investment decisions today.
26,067 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Disney reports stronger-than-expected Q2 2026 results, lifting the stock 8% in early trading as streaming and parks r...
Moderna shares rose about 6% early trading after better-than-expected Q1 results and renewed vaccine interest. Pfizer...
B&G Foods' Q1 2026 earnings set the stage for a cautious yet encouraging year. This guide breaks down the drivers, ri...
Goldman Sachs researchers contend that the U.S. labor market has improved since ChatGPT first opened its chat window,...
A large stake exit sent shockwaves through a payments stock, pulling it down by about half from its highs. This artic...
Snowflake delivered a strong fiscal quarter and unveiled a major AWS commitment, sending the stock higher. This guide...
Analysts warn that a spike to $150 oil within two to three weeks is a risk scenario, not a forecast, but markets are ...
When a chief operating officer discloses a large stock sale, it can raise questions for investors. This guide explain...
Bitcoin retraced after a volatile stretch, pushing traders to rethink income-focused strategies. This piece breaks do...
SpaceX’s emergence as a top public company captures headlines, but sustainable value hinges on cash flow, strategy, a...
AI-driven data centers are fueling a power supercycle, pushing on-site generation and turbocharging turbine prices. G...